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Summary
Rheumatoid arthritis, a disease of unknown aetiology, is characterized by joint inflammation and, in its later stages, 
cartilage destruction. Inflammatory mediators may exert not only suppression of matrix synthesis but also cartilage 
degradation, which eventually leads to severe cartilage depletion. Systemically and locally produced growth factors and 
hormones regulate cartilage metabolism. Alterations in levels of these factors or in their activity can influence the 
pathogenesis of articular cartilage destruction in arthritic joints. The main topic of the present review is the role of the 
anabolic factor insulin-like growth factor-1 in the regulation of chondrocyte metabolic functions in normal and in 
diseased cartilage. This is the most important growth factor that balances chondrocyte proteoglycan synthesis and 
catabolism to maintain a functional cartilage matrix. A brief overview of how chondrocytes keep the cartilage matrix 
intact, and how catabolic and anabolic factors are thought to be involved in pathological cartilage destruction precedes 
the review of the role of this growth factor in proteoglycan metabolism in cartilage.
Articular cartilage
Structure and function of articular cartilage
Articular cartilage forms the weight-bearing surface 
of the articular joint, providing it with a resilient, 
smoothly gliding surface. Articular cartilage consists 
of a highly organized extracellular matrix in which 
specialized cells, chondrocytes, are embedded. Ag­
gregated proteoglycans and collagen fibrils are the 
two major structural components of the matrix, and 
form a three-dimensional framework giving the 
tissue a unique architecture.
Cartilage collagen has a very low basal rate of 
turnover, and the intact collagen network provides a 
permanent framework that gives the tissue tensile
strength. Cartilage collagen consists mainly of type
II collagen, bu t cartilage also contains small 
am ounts of type VI, IX and X collagen; type X is 
restricted to the deep part of the cartilage and type 
XI is part of the collagen fibril. Moreover, type X 
collagen is mainly found in hypertrophic chondro­
cytes or in osteoarthritic cartilage (Reichenberger et 
aL, 1991; Nerlich et aL, 1992; Von der Mark et aL, 
1992; Aigner et a l ,  1993, 1995).
Proteoglycans are complex macromolecules w ith 
a high turnover rate; they consist of a core protein 
to which one or more glycosaminoglycan side 
chains or N -O linked oligosaccharides are attached 
(Handley et aL, 1985)* Glycosaminoglycan chains are 
polymers of repeating disaccharides that can vary in
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number of chains, their length as well as their 
pattern of sulphation; they play a dominant role in 
the determination of physical properties of the 
protein to which they are attached. High negatively 
charged glycosaminoglycans entrap solvent, thus 
creating a high osmotic pressure which is restrained 
by collagen. The swelling pressure, together with 
changed hydraulic permeability, enables cartilage to 
resist compressive loads with minimal deformation.
The major proteoglycan found in articular carti­
lage is aggrecan (Hardingham & Fosang, 1992, 
1995). Aggrecan molecules contain three globular 
domains (Gl, G2 and G3), of which the G1 domain 
can bind noncovalently to a single chain of 
hyaluronan, forming large macromolecular aggre­
gates. This interaction is promoted and stabilized by 
link protein (Hardingham et al„ 1992a) (Fig. 1 ). 
Furthermore, cartilage contains nonaggregated small 
proteoglycans, such as biglycan, decorin and fibro- 
modulin (Witsch-Prehm et aL, 1992), These smaller 
proteoglycans are studied intensively these days, 
but so far clear information on their function is 
scant.
An important aspect of the structural integrity of 
articular cartilage is the ability of chondrocytes to 
synthesize and degrade proteoglycans to maintain a 
functionally intact cartilage. Small perturbations in 
cartilage metabolism may lead to increased or
decreased local concentrations of matrix molecules 
which can alter physiological properties of the 
tissue. This may lead to rapid loss of tissue function 
and deterioration of the joint.
Three strikingly heterogeneous cartilage layers are 
generally recognized between the articular surface 
and the subchondral bone, i.e. surface, middle and 
deeper zones (Fig. 2) (Sampson & Cannon, 1986). 
Zonal subdivision is based on morphology, differ­
ences in cell density, the orientation, nature, content 
and distribution of proteoglycans, and the organiza­
tion of the collagen fibrillar network (Maroudas et 
aL, 1990; Siczkowski & Watt, 1990; Aydelotte & 
Keuttner, 1991; Maries et aL, 1991). Chondrocytes in 
the surface zone are small, flattened, and oriented 
parallel to the articular surface, and they are rather 
inert with respect to matrix synthesis. Chondrocytes 
in the middle zone are larger and round, whereas 
chondrocytes in the deeper zones have the largest 
size and occur usually in groups. Chondrocytes in 
the middle and deeper zones of cartilage exhibit the 
highest metabolic activity and are responsible for 
cartilage homeostasis.
Destruction of articular cartilage
During chronic joint disease, such as rheumatoid 
arthritis, progressive joint inflammation results in 
irreversible cartilage destruction, leading to erosion
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Fig. 1 . The basic structural unit of aggrecan, consisting of a core protein to which highly negatively charged 
glycosaminoglycan chains or oligosaccharides are bound. The core protein is noncovalently attached to hyaluronic acid, 
and this binding is reinforced by link proteins.
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Fig. 2. (A) Schematic drawing of histologically stained human cartilage, showing the three striking heterogeneous 
cartilage layers that are generally recognized between articular surface and subchondral bone, namely surface (I), middle 
(II) and deeper zones (III). Zonal subdivision is based on morphology, differences in cell density and orientation, nature, 
content and distribution of proteoglycans as well as organization of the collagen fibrillar network. (B-D) Schematic 
drawings of chondrocytes in the three cartilage layers. (B) Chondrocytes in the surface zone are small, flattened, oriented 
parallel to the articular surface, and are rather inert with respect to matrix synthesis. (C) Chondrocytes in the middle 
zone are larger and round. (D) Chondrocytes in the deeper zones are largest and usually occur in groups. Chondrocytes 
in the middle and deeper zones of cartilage exhibit highest metabolic activity and are responsible for cartilage 
homeostasis. (A, X390; B X5226; C, X4680; D, X5616).
of articular cartilage, injury of surrounding tissues 
and eventually permanent loss of joint function
(Fig. 3) (Kelly et a l , 1989; Harris, 1990).
For the study of processes that determine joint 
destruction in arthritic joints, animal models have 
been developed in which arthritis is induced 
experimentally. Studies performed by our group 
have revealed that the main aspects of pathological 
cartilage depletion are increased degradation of 
articular cartilage, reduced matrix synthesis, and 
chondrocyte death (Van den Berg et ah, 1981; 
Schalkwijk et ah, 1989b). Synovial cells, chondro­
cytes, and large numbers of macrophages and 
lymphocytes that infiltrate arthritic joints generate 
vast quantities of mediators during inflammation,
causing invasion and erosion of cartilage and 
subsequent cartilage destruction. These mediators 
include cytokines, proteolytic enzymes and reactive 
oxygen species. In addition, chronic interference 
with factors that upregulate synthesis of matrix 
components in chondrocytes plays an important role 
in cartilage destruction during joint inflammation 
(Schalkwijk et ah, 1989a, b; Tyler, 1989; Verschure et
ah, 1989). The importance of a balance between 
suppressive mediators, such as cytokines, proteoly­
tic enzymes or reactive oxygen species, and anabolic 
factors, such as circulating hormones and locally 
produced growth factors for the structural integrity 
of articular cartilage is emphasized in the following 
paragraphs.
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Fig. 3. Schematic representation of a normal and a 
rheumatoid arthritic knee joint. Joint inflammation is 
characterized by chronic synovitis leading to irreversible 
destruction of the articular cartilage. F =  femur, T =  tibia, 
SL = synovia] lining, AC = articular cartilage.
Catabolic factors
Cytokines
Cytokines are thought to play an important role in 
the pathogenesis of rheumatoid arthritis. These 
signal molecules mediate cell-cell interactions and 
are able to induce, amplify and maintain inflamma­
tion. Cytokines have been implicated in the release 
of enzymes capable of cartilage destruction (Baici & 
Lang, 1990; Macnaul et a l, '1990; Shapiro et a l, 1990; 
Circolo et al, 1991; Chandrasekhar & Harvey, 1992; 
Mort et al, 1993; Wahl & Corcoran, 1993), but also 
have strong effects on metabolic functions of 
chondrocytes (Holt et a l,  1992). High levels of 
interleukin-1 (IL-1), interleukin-6 (IL-6), interleukin- 
8 (IL-8), interleukin-10 (IL-10), tum our necrosis factor 
a  (TNFa), granulocyte-macrophage colony stimulat­
ing factor and leukocyte inhibitory factor respec­
tively, have been detected in the synovial fluid of 
arthritic joints; interleukin-2 (IL-2), interleukin-4 (IL-
4) and interferon y  are not elevated in arthritic joints 
(Nouri et al., 1984; Di Giovanne et a l , 1988; Houssiau 
et al., 1988; Saxne et a l,  1988; Xu et a l, 1989; Brennan 
et al., 1990; Firestein & Zvaifler, 1990; Waring et al, 
1993). However, it m ust be realized that levels of 
cytokines in synovial fluid or plasma gives only 
limited information about their penetration and 
ultimate effects in the cartilage matrix. Moreover, 
the final effect of these cytokines is a balance 
between their concentrations and the concentrations 
of their specific inhibitors (Hopkins et al, 1988;
& Burger, 1994). Moreover, responses to 
cytokines are also dependent on the presence of 
receptors on their target cells.
Dayer
identified as key mediators in the pathogenesis of 
rheumatoid arthritis (e.g. Bentzen et al, 1985; Tyler, 
1985; Benton & Tyler, 1988; Larrick & Kunkel, 1988; 
Verschure & Van Noorden, 1990; Henderson et al, 
1991; Van den Berg et al., 1991; Elliot et al, 1993; 
Arend & Dayer, 1995; Van de Loo et al, 1995b; 
Joosten et al, 1996). In our experimental models of 
arthritis, the arthritis-inducing stimulus determines 
whether TNFa drives IL-1 production, or whether 
IL-1 and TNFa are individually involved (Van den 
Berg, 1994; Joosten et al, 1995). Moreover, IL-4 and 
IL-10 are able to interfere with TNFa and IL-1 
production and they upregulate expression of their 
inhibitors, i.e. IL-1 receptor antagonist and soluble 
TNF receptor (Howard et al, 1992; Wong et al,
1993). IL-1 is a key mediator in the inhibition of 
chondrocyte proteoglycan synthesis in both antigen- 
and zymosan-induced models of rheumatoid arthri­
tis (Van de Loo & Van den Berg, 1990; Van de Loo 
et al, 1992, 1995a). Systemic treatment in vivo with 
anti-IL-1 antibodies or IL-1 receptor antagonist 
stimulates chondrocyte proteoglycan synthesis (Van 
de Loo et al, 1992, 1995a; Lethwaite et a l, 1994). In 
the collagen-induced model of rheumatoid arthritis, 
systemic treatment in vivo with anti-IL-1 antibody or 
IL-1 receptor antagonist not only reduces inhibition 
of proteoglycan synthesis in chondrocytes, but also 
reduces cartilage destruction and joint inflammation 
(Wooley et al, 1993; Van den Berg et al, 1994). 
Evidence for a direct destructive role of TNFa in 
vivo is still lacking (Van de Loo et al, 1995b; Joosten 
et al, 1996), but it can induce cartilage damage in 
vitro (Saklatvala, 1986; Wilbrink et al, 1991; Williams 
et al, 1995). Its main effect in collagen-induced 
arthritis is probably induction of early joint swelling 
(Elliot et al, 1993; Joosten et al, 1996).
can cause
Proteolytic enzymes
High levels of dégrada tive enzymes 
breakdown of articular cartilage during joint inflam­
mation. This topic is not discussed here because it 
has been reviewed extensively elsewhere (Evans, 
1991; Firestein, 1992; Buttle, 1994; Henderson & 
Blake, 1994). Metalloproteinases such as collagenase 
and stromelysin are important proteolytic enzymes 
that may be involved in destructive processes 
(Nguyen et al, 1989; Mort et al, 1993). In addition, 
cysteine and serine proteinases seem to play a 
significant role as well (Van Noorden et al, 1988; 
Maciewicz & Wotton, 1991; Ahmed et al, 1992; Esser 
et a l , 1994). Recently, some doubt was raised about 
the relevance of the above mentioned proteinases, 
and it was hypothesized that a newly described 
enzyme, aggrecanase, could be of more importance 
(e.g., Flanary & Sandy, 1994; Fosang et al, 1994;
Despite the complexity of the cytokine network Hughes et al, 1995; Lark et al, 1995).
involved in joint inflammation, IL-1 and TNFa are The activity of proteolytic enzymes is not only
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determined by the presence of the enzyme mole­
cules but also by post-translational activation pro­
cesses and interactions of enzymes with their 
endogenous inhibitors (e.g. Roose & Van Noorden, 
1995). In joint inflammation, post-translational acti­
vation may be increased, or an imbalance between 
the levels of matrix degrading enzymes and their 
inhibitors may occur (e.g. Ellis et al, 1994; Martel- 
Pelletier et al, 1994).
Reactive oxygen species
ïn addition to proteolytic breakdown, reactive oxy­
gen species that are released in vast amounts by 
inflammatory and /or phagocytic cells can cause 
degradation of the articular cartilage matrix 
(Roberts et al, 1989; Henrotin & Deby-Dupont, 
1992). In previous studies, we and others have 
shown that in vitro exposure of articular cartilage 
to reactive oxygen causes severe inhibition of 
chondrocyte proteoglycan synthesis as well as 
degradation of the aggrecan proteoglycan (Bates et 
al., 1985; Schalkwijk et al., 1985a; Schalkwijk et al.f 
1985b). However, the exact role of reactive oxygen 
species in vivo still has to be established. The 
ultimate effects of reactive oxygen species depends 
not only on their release but also on levels of 
endogenous scavenger enzymes and antioxidants 
(e.g. Schalkwijk et al., 1985a).
At present, nitric oxide (NO), a reactive oxygen 
species that is produced by NO synthase, is 
receiving a lot of attention in arthritis research. 
There is increasing evidence that nitric oxide 
production contributes to pathological features of 
joint inflammation (Evans et a i,  1995; Sakurai et a i,
1995). Nitric oxide production is regulated by 
cytokines and growth factors (Palmer et a l 1993; 
Blanco et al, 1995; Lo & Cruz, 1995). The role of 
nitric oxide has been studied by applying NO 
synthase antagonists and inhibitors. IL-1 is known 
to cause inhibition of chondrocyte proteoglycan 
synthesis through nitric oxide production (Stadler 
et al., 1991; Charles et a i,  1993; Hauselman et a l, 
1994; Taskiran et al., 1994; Fukuda et ai, 1995; 
Jarvinen et ah, 1995). Moreover, nitric oxide is 
thought to play a regulatory role in activation of 
metalloproteinases in articular chondrocytes (Murell 
et al., 1995). However, it is unclear whether nitric 
oxide is a mediator of cartilage catabolism
(Hanglow et al, 1995; Stefanofic-Racic et a l, 1996).
Anabolic factors
Rates of chondrocyte proteoglycan synthesis and 
degradation in articular cartilage are the result of 
the effects of a number of hormones and locally 
produced growth factors (Lebovitz & Eisenbarth, 
1975; Franchimont & Bassleer, 1991; Hardingham et
al, 1992b; Trippel, 1995). Hormones such as steroids, 
and growth factors such as basic fibroblast growth 
factor (bFGF), epidermal growth factor (EGF), 
platelet-derived growth factor (PDGF), transforming 
growth factor |3 (TGF|3) and insulin-like growth 
factor (IGF-1 ), are known to affect cartilage metabo­
lism. IGF-1 is the most important growth factor that 
stimulates chondrocyte proteoglycan synthesis and 
inhibits proteoglycan catabolism (Tyler, 1989). in  the 
following paragraphs, the role of steroid hormones 
and growth factors in chondrocyte proteoglycan 
metabolism will be briefly described and subse­
quently, the role of IGF-1 in cartilage metabolism 
will be reviewed.
Effect of growth factors and glucocorticoids on chondro­
cyte proteoglycan metabolism
Growth factors, such as EGF, bFGF, PDGF, TGF|3 
and IGF-1 , play a role in the regulation of chon­
drocyte proteoglycan synthesis and degradation. 
They are also important in repair processes during 
joint diseases (Cuevas et al.f 1988; Ogawa et al., 1991; 
Harvey et a l , 1993). Controversy exists about their 
relative importance in modulating chondrocyte pro­
teoglycan metabolism. It must be realized that most 
information has been gained from studies on isolated 
chondrocytes or from cartilage explants. Differences 
in experimental culture conditions, the origin and 
species from which chondrocytes or cartilage are 
obtained are all important factors that might deter­
mine the outcome of the experiments (Kato & 
Gospodarowicz, 1985b; Rosier et al, 1988; Burton- 
Wuster & Lust, 1990; Hiraki et al, 1990). Little is 
known of the role of growth factors in anatomically 
intact cartilage (Van der Kraan et al, 1992a).
bFGF and EGF stimulate proteoglycan synthesis 
strongly in actively growing growth-plate chondro­
cytes, but only to a limited extent in chondrocytes 
that have become hypertrophic (Kato & Iwamoto, 
1990; Iwamoto et al, 1991; Trippel et al., 1993; Sah et 
al, 1994; Wroblewski & Edwall-Arvidsson, 1995). 
PDGF stimulates proteoglycan synthesis to a similar 
extent as IGF-1 , whereas TGF|3 exerts both stimula­
tory and inhibitory effects on chondrocyte proteo­
glycan synthesis (Van der Kraan et al, 1992a, b; 
Morales, 1994). Furthermore, in vivo experiments 
showed that repeated intra-articular injections of 
TGF|3 into mouse knee joints induce strong and 
long-lasting stimulation of chondrocyte proteoglycan 
synthesis (Van Beuningen et al, 1993, 1994). Syner­
gistic interactions between growth factors have been 
described as well in in vitro culture experiments 
(Inoue et a l,  1989; Nataf et al, 1990; O'Keefe et al,
1994). For example, IGF-1 synergistically enhances 
chondrocyte proteoglycan synthesis induced by 
bFGF or EGF in cultured chondrocytes (Kato et al, 
1983).
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Glucocorticoids are involved in the regulation of 
long-term metabolic functions of chondrocytes, but 
their effects on chondrocyte proteoglycan metabo­
lism remain controversial. Intra-articular injections 
of glucocorticoids suppress joint inflammation and 
result in pain relief and marked preservation of 
joint function (Hollander et ah, 1951; Holden & 
Hume, 1962; Standberg, 1964; Gray & Gottlieb, 1983; 
Weiss et ah, 1990). Low levels of glucocorticoids 
stimulate chondrocyte proteoglycan synthesis in 
vitro (Kato & Gospodarowicz, 1985a; Takano et ah, 
1985; Takigawa et al., 1988; Bellows et ah, 1989). 
They also have chondroprotective effects on proteo­
glycan-depleted cartilage in vivo, by decreasing both 
inhibition of proteoglycan synthesis, and loss of 
chondrocyte proteoglycan and osteophyte formation 
(Williams & Brandt, 1985; Joosten et al., 1990; Van 
den Berg, 1991, 1992). Glucocorticoids, such as 
cortisone, prednisolone, hydrocortisone, dexametha- 
sone and triamcinolone acetonide also exert inhibi­
tory effects on chondrocyte proteoglycan synthesis 
in normal cartilage in vitro as well as in vivo 
(Mankin & Conger, 1966; Anastassiades & Dziewiat- 
kowski, 1970; Behrens et ah, 1975; Weiss et ah, 1988; 
Barrueco et ah, 1989; Chunekamrai et ah, 1989; 
Annefeld, 1992). IGF-1 and glucocorticoids have 
synergistic effects on chondrocytes (Itagane et ah,
1991), The effects of glucocorticoids on chondrocytes 
may be direct or via regulation of production of 
inflammatory mediators (Blondelon et ah, 1980; 
Sheppard et ah, 1982; Steinberg & Sledge, 1983; 
Silbermann & Maor, 1985; Shinmei et ah, 1988; Di 
Battista et ah, 1991; Itagane et ah, 1991; Price et ah, 
1992; Schlaghecke et ah, 1992).
Insulin-like growth factor (IGF)
IGFs, which were originally defined as somato- 
medins, have been reported to be: a growth 
hormone-dependent serum factor able to stimulate 
35S-sulphate incorporation into cartilage in vivo 
("sulphation factor'; Salmon & Daughaday, 1957), a 
cofactor extracted from serum able to stimulate 
replication of cells ("multiple stimulating activity7; 
Kato et ah, 1981), or a factor in serum exerting 
insulin-like activity on target tissues Cnonsuppres- 
sible insulin-like activity7; Zapf et ah, 1987).
Isolation and purification of IGF revealed that two 
forms exist: IGF-1 with a molecular mass of 7.5 kDa 
and pi of 8.5, and IGF-2 with a molecular mass of 
7.4 kDa and pi of 7.0 (Clemmons & Shaw, 1986; 
Humbel, 1990). Structural analysis at biochemical 
and genetic levels revealed that IGF-1 and IGF-2 are 
both single polypeptides with significant sequence 
similarity with insulin (Daughaday & Rotwein, 1989; 
Rotwein, 1991; Adamo et ah, 1992; Van den Brande,
1992). IGF biosynthesis is regulated by various 
hormones from the pituitary gland, such as growth
hormone, adrenocorticotropic hormone, luteinizing 
hormone, follicle-stimulating hormone and thyroid- 
stimulating hormone, and growth factors such as 
PDGF and bFGF. IGF is produced in significant 
amounts after tissue injury or during malnutrition 
(Smith et ah, 1989a; Isaksson et ah, 1991; Nissley & 
Lopaczynski, 1991). It was originally thought that 
this growth factor was produced by the liver and 
acted as a hormone (Hall & Tally, 1989). Now it is 
generally recognized that it is synthesized by 
numerous types of cells and tissues, suggesting that 
it acts via autocrine/paracrine as well as endocrine 
pathways (Daughaday, 1990; Phillips et ah, 1990; Le 
Roith & Roberts, 1991; Bang & Hall, 1992; Isgaard, 
1992; Jennische et ah, 1992; Middleton & Tyler, 1992; 
Lazowski et ah, 1994). IGF levels in serum (20- 
80 nM) are higher than in tissues. However, IGF in 
serum is largely bound to specific IGF-binding 
proteins (IGFBPs) which prolong its half life 
(Adamo et ah, 1992). Therefore, the physiologically 
relevant levels of IGF may be tissue levels rather 
than serum levels. It has been suggested that IGF-1 
is an important postnatal growth factor, affecting 
development and metabolism of many tissues other 
than cartilage (Demarquay et ah, 1990). IGF-2 plays 
a regulatory role in glucose metabolism and may be 
even more important as a fetal growth factor 
(Bhaumick & Bala, 1991).
IGF receptors
Biological action of IGF-1 and IGF-2 is initiated by 
binding to their specific cell surface receptors, which 
differ significantly in structure and peptide binding 
specificity (Fig. 4) (Czech et ah, 1989; Smith et ah, 
1989b; Yokono et ah, 1989). IGF-1 binds preferentially 
to the type 1 receptor, and IGF-2 to the type 2 
receptor, although both receptors can bind the other 
IGF with lower affinity (Le Roith et ah, 1991; 
Tollefsen et ah, 1991). Type 1 receptor is a hetero- 
tetrameric glycoprotein consisting of two extracellu­
lar a subunits with a molecular mass of 130 kDa, and 
two transmembrane (3 subunits with a molecular 
mass of 95 kDa. The a  and |3 subunits are held 
together by disulphide bonds, thus forming a 
tetramer consisting of two a|3 dimers (Ullrich et ah, 
1986; Le Roith & Raizada, 1989; Neely et ah, 1991).
Type 1 receptor is formed as a precursor protein that 
needs a number of post-transcriptional and post- 
translational modifications including glycosylation, 
dimerization and proteolytic processing to yield the 
mature complex consisting of two a|3 subunits 
(Rechler & Nissley, 1990; Moxham & Jacobs, 1992). 
The ligand binding site is located in the extracellular 
a  subunit, whereas the intracellular (3 subunit 
contains a tyrosine kinase domain responsible for 
signal transduction (Kjeldsen et ah, 1991; Zhang & 
Roth, 1991). Association of two a(3 dimers is required
VERSCHURE et ah
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Fig. 4. Structure of the type 1 and type 2 IGF receptors. The type 1 receptor is a heterotetrameric complex composed of 
two extracellular a subunits and two transmembrane (3 subunits held together by disulphide bonds. The a subunits bind 
IGF-1 and the |3 subunits contain tyrosine kinase activity in their cytoplasmic domain. The type 2 receptor has a short 
cytoplasmic tail and a large extracellular domain, consisting of many cysteine-rich regions.
for receptor signal transduction after ligand binding 
(Ikari et al, 1988; Tollefsen & Thom pson 1988; 
Wilden et al., 1989; Soos et al., 1990). IGF-1 binding 
to the a  subunit results in intracellular signal 
transduction by autophosphorylation of the (3 sub­
unit and activation of the receptor tyrosine kinase. 
Tyrosine kinase is responsible for intracellular signal 
transduction, initiating a cascade of phosphorylation 
steps including activation of serine and threonine 
kinases (Corps, 1990). Recently, signal transduction 
from the IGF-'l type 1 receptor via tyrosine kinase 
receptor has been linked w ith the G protein- 
associated phosphatidylinositol hydrolysis pathway, 
in a way similar to that described for other growth 
factor receptors (Cantley et al., 1991; Malcolm &: 
Wright, 1993). After IGF binding and signal trans­
duction, the type 1 receptor is internalized and 
recycled to the cell surface. The number of type 1 
receptors at the cell surface is downregulated by 
increasing concentrations of IGF-1 (Schalch et al., 
1986).
Type 2 receptor is a single chain polypeptide with 
a molecular mass of 250 kDa consisting of a single 
transmembrane region and a large extracellular 
domain (Dahms et al., 1987). This receptor does 
not seem to have signalling functions similar to the 
type 1 receptor (Haig & Graham, 1991). Type 2 
receptor is identical to the cation-independent 
mannose-6-phosphate receptor, which binds lyso­
somal proteins and mediates their transport to the 
lysosomes (Poiraudeau et a l 1994). The mechanism 
of action of the type 2 receptor was also found to be
mediated via the G protein-associated phosphatidyl­
inositol hydrolysis pathway (Nishimoto et al., 1989).
IGF binding proteins (IGFBPs)
IGF binding proteins (IGFBPs) are proteins with high 
affinity for insulin-like growth factors. Their inter­
action plays an essential role in m odulating bio­
logical functions of these growth factors (Baxter,
1993), Multiple binding proteins have been detected 
in plasma, amniotic fluid and spinal fluid and in a 
variety of tissues. Despite a large similarity in 
structure, the different binding proteins have dis­
tinctly different properties that might provide clues 
to elucidate their exact functions (Baxter, 1991; 
Lamson et al., 1991). Six classes of these binding 
proteins, designated IGFBP-1 to 6, have been 
purified and cloned so far (Drop et ah, 1992; 
Bhaumick, 1993). In serum, they function as a storage 
depot allowing a ready supply of insulin-like growth 
factor to tissues. The proteins can bind the growth 
factor either to sequester it so as to prevent its 
binding to its receptors, or to present IGF to the 
receptor so as to improve ligand-receptor inter­
actions, depending upon the structural and biochem­
ical properties of the binding proteins. The ability of 
IGFBPs to adhere to the cell surface appears to be 
im portant in the latter process, IGFBP-1 and IGFBP-2 
have RGD sequences (Arg-Gly-Asp) in their terminal 
region and are therefore structurally capable of 
binding to integrin receptors at the cell surface 
(Ruoslahti &: Pierschbacher 1987; Brewer et al., 1988), 
The agonistic or antagonistic nature of IGFBP
a a u
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modulation of the biological functions of IGF 
depends on the cell or tissue types involved 
{Baxter & Martin, 1989; Sara & Hall, 1990).
Chondrocytes produce IGFBPs (Froger-Gaillard 
et ah, 1989; Tesch et a l,  1992; Olney et al., 1993; 
Chevalier & Tyler, 1994). In osteoarthritis, produc­
tion of IGFBP-3 and 5 by chondrocytes is increased 
(Dore et ah, 1994; Olney et al., 1996; Tardif et al., 
1996; Chevalier & Tyler, 1996), which indicates that 
IGFBPs are involved in pathological cartilage de­
struction.
Effects of IGF on proteoglycan metabolism in cartilage
IGF-1 is the major growth factor that balances 
proteoglycan biosynthesis and breakdown in chon­
drocytes for the maintenance of the cartilage matrix 
(Schoenle et a l , 1982; Hascall et al., 1983; Froesch et
ai, 1985; McQuillan et al., 1986; Luyten et al., 1988; 
Schalkwijk et al., 1989a; Curtis et al., 1992; Middleton 
& Tyler, 1992). IGF-1 can stimulate chondrocyte 
proteoglycan synthesis in culture in the absence of 
foetal calf serum (Barone-Varelas et al., 1991; Bohme 
et ai, 1992) and it can directly inhibit both basal and 
cytokine-induced degradation of proteoglycan in 
cartilage (Tyler, 1989). IGF-2 is less potent than 
IGF-1, requiring 50-100 times higher concentrations 
to achieve similar effects (Luyten et a i,  1988). 
Selective elimination of IGF-1 from serum or 
synovial fluid with neutralizing antibodies results 
in a distinct decrease in cartilage proteoglycan 
synthesis and enhanced proteoglycan breakdown 
(Schalkwijk et al,, 1989a). IGF-1 seems to inhibit 
production and release of proteases or protease 
activators, although evidence is not yet conclusive 
(Ballard et a i, 1986; Chandrasekhar et ai, 1992; 
Padayatty et ai, 1993).
IGF binding sites on chondrocytes in articular 
cartilage have been identified as specific IGF 
receptors (Postel-Vinay et a l,  1983; Trippel et a l , 
1983, 1988; Watanabe et ah, 1985; Jansen et ah, 1989; 
Makower et al.f 1989; Yasunaga et ah, 1995). Trippel 
et ah (1988) calculated that an average of 3 X 104 
type 1 receptors are present on the surface of each 
chondrocyte with a binding affinity to IGF-1 of 
4 X 10-® M.
The effects of IGF-1 and IL-1 are opposite: IGF-1 
can speed up recovery from IL-1-induced inhibition 
of chondrocyte proteoglycan synthesis, while IL-1 
promotes cartilage breakdown by inhibiting IGF-1 - 
stimulated synthesis (Taylor et ah, 1988; Fosang et 
ah, 1991; Berenbaum et ah, 1994; Neidel et ah, 1994; 
Rayan & Hardingham, 1994). IL-1 downregulates 
IGF mRNA levels in chondrocytes and induces 
secretion of IGFBP and IGF-1 receptor, indicating 
that an autocrine loop regulates IGF-1 function 
(Lazarus et ah, 1993; Matsumoto et ah, 1994). These
findings suggest that IL-1 and IGF may play 
significant roles in the pathogenesis of inflammatory 
joint diseases.
IGF-1 nonresponsiveness of chondrocytes
Despite the importance of IGF in the regulation of 
proteoglycan metabolism in chondrocytes, only a 
limited number of studies have been focused on the 
role of IGF in rheumatoid arthritis. Measurements of 
IGF levels in serum or synovial fluid of patients with 
various types of arthritis yielded conflicting results 
(Coates et ah, 1977, 1978; Bennett et ah, 1988; Nuvert- 
Zwart et ah, 1988; Aitman et ah, 1989; Allen et ah, 
1991; Keyzer et ah, 1995). However, it has now 
become clear that lower levels of IGF-1 in serum or 
synovial fluid and/or decreased availability of IGF-1 
are not necessarily the main factors that regulate 
cartilage metabolism.
Recently, it was demonstrated in our laboratory 
that IGF-1 is essential to maintain chondrocyte 
proteoglycan synthesis during culture of intact 
cartilage (Schalkwijk et ah, 1989a). However, cul­
tured, experimentally induced, arthritic cartilage 
obtained from inflamed joints was nonresponsive 
to IGF-1 (Schalkwijk et ah, 1989b). This phenomenon 
was not caused by total nonresponsiveness of the 
chondrocytes, since forskolin, which is an upregu- 
lator of the adenylate cyclase pathway, could 
stimulate chondrocyte proteoglycan synthesis. It 
was suggested that this nonresponsiveness to IGF 
contributes to cartilage destruction (Schalkwijk et ah, 
1989b, Van den Berg et ah, 1989). Therefore, the 
exact role of IGF-1 , and the mechanism by which 
IGF-1 regulates chondrocyte proteoglycan metabo­
lism in normal and experimentally induced arthritic 
cartilage, were studied (Table 1). These studies are 
reviewed in the following paragraphs.
Regulation of IGF-1 nonresponsiveness by growth factors 
and glucocorticoids
The in vitro effects of IGF-1 and triamcinolone 
acetonide on the hydrodynamic volume of newly 
synthesized proteoglycans in normal and arthritic 
mouse cartilage have been investigated (Van der 
Kraan et ah, 1993; Verschure et ah, 1994a). In vitro 
IGF-1 stimulation of chondrocyte proteoglycan 
synthesis in normal cartilage resulted in the synth­
esis of hydrodynamically large proteoglycans, which 
is identical to the in vivo situation. In arthritic 
cartilage, IGF-1 was unable to stimulate chondrocyte 
proteoglycan synthesis and only small proteoglycan 
monomers were synthesized, demonstrating that in 
arthritic cartilage not only are the amounts of 
proteoglycan that are synthesized decreased, but 
also that their quality is inferior. In the presence of 
triamcinolone acetonide, hydrodynamically large 
proteoglycans were synthesized both in normal and
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Table 1. Overview of the role of IGF-1 and the mechanism by which IGF-1 regulates chondrocyte proteoglycan 
metabolism in mouse normal and experimentally-induced arthritic and human osteoarthritic cartilage to provide insight 
in IGF-1-related processes underlying cartilage destruction
Normal cartilage
IGF-1 can maintain in vitro synthesis of proteoglycan monomers with large hydrodynamic size at similar levels as 
occur in vivo
Glucocorticoids are able to exert similar effects as IGF-1 on the regulation of in vitro chondrocyte proteoglycan 
metabolism
PDGF and bFGF have an additional effect on IGF-1 regulation of chondrocyte proteoglycan synthesis during 
culture, EGF and TGFp have an inhibitory effect on chondrocyte proteoglycan synthesis 
IGF-1 receptors are located at the cell membrane of chondrocytes in the middle and deeper zones of cartilage, 
whereas intracellular labelling is found in surface zone chondrocytes 
Arthritic cartilage
IGF-1 nonresponsiveness during arthritis is highly correlated with the severity of arthritis
The failure of IGF-1 to stimulate in vitro  chondrocyte proteoglycan synthesis in arthritic cartilage accompanies the 
synthesis of small proteoglycan monomers, demonstrating that not only the amount but also the quality of 
synthesized proteoglycan has deteriorated in arthritic cartilage 
Chondrocytes from arthritic cartilage do not respond to other growth factors besides IGF-1 during culture 
Glucocorticoids are able to bypass disturbed IGF-1 responsiveness and may therefore play an important role in 
maintaining cartilage integrity in arthritic cartilage 
Metalloproteinases and cysteineproteinases, reactive oxygen species, IL-1, and TNFa are not key factors in the 
maintenance of IGF-1 nonresponsiveness, IL-1 does not induce IGF-1 nonresponsiveness but is indirectly involved 
in the generation of this phenomenon 
The correlation of chondrocyte IGF-1 receptor expression with in vitro IGF-1 stimulation and metabolic activity is 
disturbed in arthritic cartilage 
Chondrocytes in arthritic cartilage do not exhibit decreased amounts of IGF-1 receptor on their cell membrane. 
Therefore, IGF-1 nonresponsiveness cannot be explained by a decreased receptor expression 
Osteoa rthritic cartilage
IGF-1 has different effects on chondrocytes in the different cartilage zones in normal cartilage. This metabolic 
heterogeneity is lost in osteoarthritic cartilage. In such cartilage, chondrocyte proteoglycan synthesis and IGF-1 
receptor distribution are dependent on the stage of osteoarthritis
arthritic cartilage. It was concluded that glucocorti­
coids may play an essential role in maintaining 
cartilage integrity in both normal and arthritic 
cartilage.
Furthermore, in vitro investigations were carried 
out to study the effects of other grow th factors 
besides IGF-1 , such as bFGF, EGF, PDGF and TGF|3 
on the regulation of chondrocyte proteoglycan 
metabolism under normal and pathological condi­
tions (Verschure et al., 1994b). It was investigated 
whether these factors could compensate for IGF-1 
nonresponsiveness of the chondrocyte either during 
repair or during early an d /o r later phases of 
experimental arthritis. In normal cartilage, none of 
the growth factors tested stimulated in vitro chon­
drocyte proteoglycan synthesis as IGF-1 did. EGF 
and TGF(3 even inhibited chondrocyte proteoglycan 
synthesis. Combinations of bFGF or PDGF with 
IGF-1 exerted significant additional stimulation of 
chondrocyte proteoglycan synthesis. Norm al carti­
lage that was previously exposed to IL-1 in vivo was 
responsive to IGF-1 and to other grow th factors in a 
similar way as. to normal cartilage. However, 
experimentally induced arthritic cartilage exhibited 
a state of nonresponsiveness to all individual
growth factors tested, as well as to combinations of 
growth factors. This suggests that during the 
inflammatory process in the joint, chondrocytes 
display a general deficiency of receptor functions. 
Apparently, inflammatory processes during experi­
mental arthritis are more complex than processes 
caused by injecting IL-1 into the knee joints alone.
Regulation of IGF-1 nonresponsiveness by inflammatory 
mediators
Studies were carried out to see whether the state of
4
nonresponsiveness to IGF-1 during arthritis was 
caused by either inflammatory mediators such as 
IL-1, TNFa, or by proteolytic enzymes or reactive 
oxygen species (Verschure et ah, 1995a). Mediators 
from tissues surrounding patellar cartilage were able 
to suppress in vitro responses of chondrocytes to 
IGF-1 . Priming of normal cartilage with IL-1 did not 
completely induce IGF-1 nonresponsiveness, but 
enhanced the ability of suppressive mediators to 
downregulate the IGF-1 response. Treatment of the 
cartilage with antibodies against IL-1 a and IL-lj3, or 
IL-1 receptor antagonist, or antibodies against TNFa, 
or selective inhibitors of proteolytic enzymes or of 
reactive oxygen species, did not counteract the
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nonresponsiveness to IGF-1 in vitro. However, treat­
ment with anti-IL-la and anti-IL-lp antibodies 
before induction of arthritis abolished nonrespon­
siveness to IGF-1 . It was concluded that neither 
metalloproteinases and cysteine proteinases nor 
reactive oxygen species are key factors in IGF-1 
nonresponsiveness, and that IL-1 and TNFa alone 
are not essential for the maintenance of nonrespon­
siveness. Moreover, IL-1 does not induce IGF-1 
nonresponsiveness but is indirectly involved.
Regulation of IGF-1 nonresponsiveness by IGF-1 receptor
The lack of effects of IGF-1 on chondrocytes during 
arthritis may be due to a defect at the level of IGF-1 
receptor binding or postreceptor signalling. There­
fore, the amounts and distribution patterns of IGF-1 
receptors on the cell membrane of chondrocytes 
were investigated in normal and arthritic cartilage by 
immunohis to chemical localization and by quantifica­
tion of IGF-1 receptor (Verschure et al, 1994c). 
Immunohistochemical labelling of the IGF-1 receptor 
was performed on cryostat sections of mouse 
patellas using antibodies against the a  subunit of 
the receptor, and was visualized with confocal laser 
scanning microscopy (CLSM). Optical sectioning 
using this technique resulted in improved spatial 
resolution of the localization of the IGF-1 receptor in 
chondrocytes, and allowed peripheral labelling to 
be distinguished quantitatively from intracellular 
labelling in mouse normal and arthritic cartilage 
(Verschure et a l , 1995b; Verschure et a l,  1996a), as 
well as in human normal and osteoarthritic cartilage 
(Verschure et a i,  1996b) (Figs 5 and 6). Discrimina­
tion of specific signals from background labelling, 
which is difficult when labelling is of low intensity, 
and background and autofluorescence levels are 
high, can be accomplished by the application of 
confocal microscopy (Wilson et al., 1989; Van 
Oostvelt & Bauwens, 1990; Wells et a l,  1989), This 
is a problem that is inherent to articular cartilage, 
and therefore CLSM will become increasingly im­
portant in cartilage research. Most of the IGF-1 
receptor fluorescence was found on chondrocytes of 
the middle and deeper zones of the cartilage, 
whereas surface zone chondrocytes exhibited negli­
gible fluorescence. The heterogeneous distribution of 
IGF-1 receptor in chondrocytes of articular cartilage 
suggests that effects of IGF-1 on chondrocytes may 
be distinctly different in the specific cartilage zones.
Confocal laser scanning microscopy was applied 
to compare labelling of IGF-1 receptor by anti-IGF-1 
receptor antibody with labelling of binding sites 
with biotinylated IGF-1 in the various cartilage 
zones of normal and experimental arthritic knee 
joints (Verschure et al., 1996c). In normal cartilage, 
IGF-1 receptors were found at the cell membrane of 
chondrocytes of the m iddle and deep cartilage
zones with anti-IGF-1 receptor antibody, whereas 
intracellular labelling was highest in chondrocytes 
of the surface zone. After incubation with biotinyl­
ated IGF-1, distinct membrane labelling was not 
present. In normal cartilage, fluorescence was found 
to be distributed homogeneously in chondrocytes of 
the middle and deep zones but not in the surface 
zone. In cartilage from inflamed knee joints, label­
ling with anti-IGF-1 receptor antibody was not 
significantly different from normal cartilage, 
whereas labelling with biotinylated IGF-1 was 
increased in chondrocytes of the middle and deeper 
zones of arthritic cartilage as compared with normal 
cartilage. The lack of intracellular labelling with 
biotinylated IGF-1 of surface zone chondrocytes 
may suggest that intracellular IGF-1 binding sites 
have low affinity for IGF-1 , or that the binding site 
of the receptor is shielded. Labelling patterns 
obtained with biotinylated IGF-1 also display IGF-
1 binding proteins (IGFBPs). It was suggested that 
during joint inflammation larger amounts of these 
binding proteins are present.
Both the distribution patterns of IGF-1 receptor, 
and in vitro IGF-1 stimulation of chondrocyte 
proteoglycan synthesis were examined in articular 
cartilage of normal and experimental arthritic 
mouse knee joints during various phases of arthritis 
(Verschure et ah, 1995b). The distribution patterns of 
IGF-1 receptor expression in the different cartilage 
zones of normal cartilage reflected IGF-1 stimulation 
and proteoglycan synthetic activity of chondrocytes 
in these layers. Concurrently with the development 
of arthritis, cartilage lost its capacity to react to IGF-
1 , but when the inflammatory response was waning, 
IGF-1 responsiveness returned. Shortly after induc­
tion of experimental arthritis, a clear decrease in 
IGF-1 receptor expression was observed, whereas in 
later phases of arthritis receptor expression returned 
to normal levels. It was found that IGF-1 nonre­
sponsiveness was highly correlated with severity of 
arthritis. The correlation of IGF-1 receptor expres­
sion with IGF-1 stimulation and metabolic activity is 
disturbed in arthritic cartilage, suggesting inade­
quate or abolished intracellular signal transduction 
in chondrocytes.
It was also studied whether chondrocyte proteo­
glycan synthesis correlates with chondrocyte IGF-1 
receptor expression in human normal cartilage, as 
well as in cartilage known to display a shift in 
proteoglycan synthesis, such as cultured cartilage 
and osteoarthritic cartilage (Verschure et al., 1996b). 
Osteoarthritic cartilage shows markedly enhanced 
proteoglycan synthesis. Cartilage specimens were 
obtained post mortem from human knees within 18 
hours after the death of donors with no known 
clinical history of osteoarthritis. The samples were 
dissected from macroscopically normal regions as
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Fig. 5. (A) Schematic drawing of a confocal laser scanning microscope (CLSM), It collects images that are almost free of 
out-of-focus signals. This type of analysis results in improved spatial resolution as compared with conventional light 
microscopy and allows optical sectioning of the specimen (White et ah, 1988; Wilson, 1989). (B) The possibility of making 
optical sections through the entire chondrocyte has been applied to the analysis of IGF-1 receptor labelling in the 
chondrocyte in the middle optical section.
glycan synthesis activity and chondrocyte IGF-1 
receptor labelling were found in moderate osteo­
arthritis, whereas low levels of proteoglycan synth­
esis and IGF-1 receptor labelling were observed in 
severe osteoarthritis.
well as from damaged regions. This procedure 
yielded a range of grades from mild to moderate 
and severe osteoarthritis. In normal cartilage, both 
chondrocyte proteoglycan synthesis and the amount 
of chondrocyte IGF-1 receptor were low in the 
surface zones, and high in the middle and deep 
zone of the cartilage. After culture, an increase in 
chondrocyte proteoglycan synthesis in the surface 
zone coincided with upregulation of IGF-1 receptor 
localisation. In mild osteoarthritis, particularly high 
levels of chondrocyte synthetic activity were found 
in the upper cartilage layer, whereas IGF-1 receptor im portant growth factor that regulates chondrocyte 
expression was low in this layer, suggesting that proteoglycan metabolism, by binding to the type 1 
factors other than IGF-1 are involved in enhancing receptor. In the present review it is shown that IGF-1 
chondrocyte proteoglycan synthesis. H igh proteo- receptor distribution patterns in surface, m iddle and
Final considerations
A critical aspect of the structural integrity of articular 
cartilage is the ability of chondrocytes to synthesize 
and degrade proteoglycans. IGF-1 is the most
Fig. 6, Pseudo 3-D visualization of a CLSM data stack; consecutive sections of a chondrocyte located in the
zone5 mouse articular cartila.ee after being immunohistochemically labelled for the rec
filing with a antibody against theChondrocytes located in the middle zone of normal mouse cartilage after 
a  subunit of the IGF-1 receptor. The chondrocyte membrane contains large amounts of IGF-1 receptor fluorescence but
in,g is weak. {B, C) Chondrocytes located in the middle zone of mouse normal (B) or arthritic articular
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may indicate that, although IGF-1 receptors are 
present on the chondrocyte membrane, the mem­
brane lipid bilayer composition may have changed, 
causing altered configuration of the transmembrane 
receptor, which may hamper the biological function 
of the receptor. Furthermore, receptors may be 
masked or damaged by agents produced by the 
inflamed synovium (Jansen et al., 1989; Kwok et al., 
1989; Bergstedt & Wieloch, 1993; Kato et a l, 1993). 
For instance, IGFBPs may play a role in this process 
(Tesch et a l, 1992; Chevalier & Tyler, 1994). In 
osteoarthritic human cartilage, elevated IGFBP levels 
seem to be involved in capturing IGF-1 and there­
fore in reduced bioavailability of IGF (Dore et al., 
1994; Olney et al., 1996; Chevalier & Tyler, 1996; 
Tardif et al., 1996). Increased labelling in chondro­
cytes of arthritic cartilage after incubation with 
biotinylated IGF-1 may indicate increased levels of 
IGFBPs. However, even at unphysiologically high 
concentrations of IGF-1 chondrocyte proteoglycan 
synthesis is not stimulated in vitro and chondrocytes 
maintain their nonresponsiveness to IGF-1 . There­
fore, if IGFBPs are produced in high concentrations 
they may be involved in the IGF-1 nonresponsive 
state during arthritis.
Alternatively, IGF-1 receptors may be defective 
and unable to exhibit normal biological functions 
(Soos & Siddle, 1989; Raz et a l, 1991; Zhang & Roth, 
1991; Attisano et a l, 1992; Miki et a l, 1992; Werner 
et a l, 1992). Yee et a l (1989) have found an 
alternative IGF-1 receptor transcript w ith a 3-base 
deletion in many tissues and cell lines. It would be 
interesting to investigate whether this alternatively 
spliced mRNA of IGF-1 receptor is also present in 
arthritic chondrocytes but not in normal chondro­
cytes. At present, this hypothesis is investigated by 
detecting the two different spliced IGF-1 receptor 
mRNAs with the use of the polymerase chain 
reaction. In addition, the composition of chondro­
cyte membranes may be changed and thus also the 
function of transmembrane proteins, such as the (3 
subunits of the IGF-1 receptor, that are involved in 
signal transduction pathways. Therefore, possible 
defects in the phosphorylation pathways leading to 
receptor signalling w ill be another interesting item 
for further research. However, these experiments 
may introduce artefacts: isolation and subsequent 
culture of chondrocytes from arthritic knee joints 
may change the 'arthritic' phenotype of the cells. 
Moreover, analysis of whole chondrocyte popula­
tions leads to loss of information about individual 
chondrocytes located in the different cartilage 
layers.
Although arthritis seemed to cause a nonrespon­
sive state to a whole range of potential anabolic 
growth factors, the glucocorticoid triamcinolone 
acetonide can maintain in vitro chondrocyte proteo­
glycan metabolism. Glucocorticoids may have an 
indirect effect on chondrocytes in arthritic cartilage; 
they can modulate the production of inflammatory 
mediators (Sheppard et al, 1982; Steinberg & Sledge, 
1983), and seem to have a priming effect on the 
biological action of IGF-1 in cartilage metabolism 
(Itagane et a l, 1991; Price et a l, 1992). In  a previous 
study, it was shown that a single intra-articular 
injection in arthritic joints of a depot preparation of 
the steroid triamcinolone hexacetonide or rimexo- 
lone counteracts the severe suppression of chondro­
cyte proteoglycan synthesis in arthritic cartilage 
(Joosten et al., 1990). These steroid-treated arthritic 
joints show normal responsiveness to IGF-1 (Joosten 
et al. unpublished results). In this respect, it will be 
interesting to analyse whether, at later stages of 
arthritis or after renewed exacerbation, chondrocytes 
still display their responsiveness induced by gluco­
corticoids.
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